Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes

AIM: To compare day‐to‐day and within‐day variability in glucose‐lowering effect between insulin degludec (IDeg) and insulin glargine 300 U/mL (IGlar‐U300) in type 1 diabetes. MATERIALS AND METHODS: In this double‐blind, crossover study, patients were randomly assigned to 0.4 U/kg of IDeg or IGlar‐U...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Obes Metab
Egile Nagusiak: Heise, Tim, Nørskov, Marianne, Nosek, Leszek, Kaplan, Kadriye, Famulla, Susanne, Haahr, Hanne L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2017
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485013/
https://ncbi.nlm.nih.gov/pubmed/28295934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12938
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak